Former health secretary takes on another advisory role in private health sectorBMJ 2015; 351 doi: https://doi.org/10.1136/bmj.h6201 (Published 17 November 2015) Cite this as: BMJ 2015;351:h6201
- Gareth Iacobucci
- 1The BMJ
The former health secretary for England, Andrew Lansley, has taken on a role advising the drug company Roche, prompting fresh concerns over the “revolving door” between the government and industry.
Lansley, who was appointed to the House of Lords last month after stepping down as an MP in May 2015, has declared in his register of interests that he is advising the company on pharmaceutical supply and pricing issues in Europe until the end of November 2015.1
Roche was one of the main beneficiaries of the Cancer Drugs Fund that Lansley set up in 2010 and was recently in dispute with the NHS in England over the price of the breast cancer drug Kadcyla. The UK National Institute for …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial